Refine
Document Type
- Article (36)
- Doctoral Thesis (2)
Language
- English (38) (remove)
Has Fulltext
- yes (38)
Is part of the Bibliography
- no (38)
Keywords
- - (26)
- MRSA (4)
- melioidosis (4)
- Germany (3)
- antimicrobial resistance (3)
- coagulase-negative staphylococci (3)
- infection prevention (3)
- susceptibility testing (3)
- <i>Burkholderia pseudomallei</i> (2)
- Burkholderia pseudomallei (2)
- ESBL (2)
- North Rhine–Westphalia (2)
- T cell receptor signaling (2)
- Vietnam (2)
- biofilm (2)
- environment (2)
- hand hygiene (2)
- infectious disease (2)
- primary school children (2)
- public awareness (2)
- questionnaire (2)
- resistance (2)
- sanitary facilities (2)
- sodium bituminosulfonate (2)
- <i>Candida lusitaniae</i> (1)
- <i>Staphylococcus aureus</i> (1)
- <i>Staphylococcus lugdunensis</i> (1)
- <i>Streptococcus pneumoniae</i> (1)
- <i>agr</i> type (1)
- <i>spa</i> type (1)
- AMR (1)
- Actinobacteria (1)
- Africa (1)
- Allogeneic stem cell transplantation (1)
- BK virus (1)
- BRAFV600E mutation (1)
- BRAFi-resistance (1)
- DUBs (1)
- E3 ligases (1)
- ESBL- (1)
- Enterobacterales (1)
- Enterobacteriaceae (1)
- Euregio (1)
- Firmicutes (1)
- G-quadruplexes (1)
- Haemorrhagic cystitis (1)
- IncN (1)
- Kv1.3 potassium channel (1)
- LL-37 (1)
- LMP (1)
- LPXTG (1)
- MALDI-TOF (1)
- MALDI-TOF MS (1)
- MDRE (1)
- MDRO (1)
- MHC class I (1)
- MRSA - Methicillin-resistant (1)
- Macrococcus (1)
- Mecklenburg-Western Pomerania (1)
- Melanoma (1)
- Melioidosis (1)
- Middle East (1)
- NorA (1)
- One Health (1)
- Panton-Valentine leukocidin (1)
- Proteasome inhibitor (1)
- Proteobacteria (1)
- SARS-CoV-2 (1)
- SHP2 gain-of-function mutation (1)
- SUMO (1)
- South West India (1)
- Src homology region 2 domain-containing protein-tyrosine phosphatase 2 (SHP2) (1)
- Staphylococcus (1)
- T cell function (1)
- T lymphocyte (1)
- Toxoplasma (1)
- VIM (1)
- Western blot (1)
- adaptation (1)
- adhesion (1)
- agar (1)
- animal (1)
- antibiotic resistance (1)
- antibiotic use (1)
- antigen presentation (1)
- antimicrobial peptides (1)
- antimicrobial resistance (AMR) (1)
- antimicrobial susceptibility testing (1)
- apoptosis (1)
- automatic counts (1)
- bacteremia (1)
- bacteria (1)
- bacterial culture (1)
- bactericidal activity (1)
- bacteriophage (1)
- birds (1)
- blood culture (1)
- breakthrough (1)
- c-myc (1)
- calorimetry (1)
- candidemia (1)
- carbapenamase (1)
- cerebral toxoplasmosis (1)
- clinical drugs (1)
- colony counting (1)
- community settings (1)
- culture based method (1)
- deubiquitination (1)
- diagnostics (1)
- direct-on-target microdroplet growth assay (1)
- dot blot (1)
- effector memory T cells (TEMs) (1)
- endolysin (1)
- enolase (1)
- environmental surveillance (1)
- epidemiology (1)
- epidermal differentiation inhibitors (1)
- exfoliative toxins (1)
- extracellular matrix proteins (1)
- fusidic acid (1)
- genomic epidemiology (1)
- genomics (1)
- glycolysis (1)
- hBD3 (1)
- immunoproteasome (1)
- immunoproteomics (1)
- in vitro stability (1)
- infection (1)
- linear gradient (1)
- machine learning (1)
- mallard ducks (1)
- mass spectometry (1)
- mercury (1)
- methicillin-resistant <i>Staphylococcus aureus</i> (1)
- microbiota (1)
- moonlighting proteins (1)
- mortality (1)
- multidrug resistance (1)
- n/a (1)
- neuroinflammation (1)
- nosocomial infection (1)
- nuclease (1)
- paratuberculosis (1)
- physicochemical factors (1)
- pig (1)
- plasminogen plasmin system (1)
- platelet activation (1)
- point mutation (1)
- proteasome endopeptidase complex (1)
- protein interaction (1)
- protein kinase (1)
- proteomics (1)
- pyrogenic toxin superantigens (1)
- qPCR (1)
- random forests (1)
- rapid testing (1)
- re-growth (1)
- resistance detection (1)
- seasonal variation (1)
- sentinel (1)
- skin and soft-tissue infections (1)
- soil (1)
- sortase A (1)
- ssp. (1)
- staphylococci (1)
- sub-inhibitory concentrations (1)
- surface proteins (1)
- surgical patients (1)
- surveillance (1)
- test standardization (1)
- thermodynamics (1)
- toxin genes (1)
- transplantation (1)
- trends (1)
- ubiquitin (1)
- ubiquitination (1)
- variable selection (1)
- viral replication (1)
- volatile organic compound (1)
- whole genome sequencing (1)
- yeast (1)
Institute
- Friedrich-Loeffler-Institut für Medizinische Mikrobiologie (38) (remove)
Publisher
- MDPI (19)
- Frontiers Media S.A. (10)
- Wiley (2)
- American Society for Microbiology (ASM) (1)
- Elsevier (1)
- S. Karger AG (1)
- Taylor & Francis (1)
Background: For years, coagulase-negative staphylococci (CoNS) were not considered a cause of bloodstream infections (BSIs) and were often regarded as contamination. However, the association of CoNS with nosocomial infections is increasingly recognized. The identification of more than 40 different CoNS species has been driven by the introduction of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Yet, treatment guidelines consider CoNS as a whole group, despite increasing antibiotic resistance (ABR) in CoNS. This retrospective study provides an in-depth data analysis of CoNS isolates found in human blood culture isolates between 2013 and 2019 in the entire region of the Northern Netherlands. Methods: In total, 10,796 patients were included that were hospitalized in one of the 15 hospitals in the region, leading to 14,992 CoNS isolates for (ABR) data analysis. CoNS accounted for 27.6% of all available 71,632 blood culture isolates. EUCAST Expert rules were applied to correct for errors in antibiotic test results. Results: A total of 27 different CoNS species were found. Major differences were observed in occurrence and ABR profiles. The top five species covered 97.1% of all included isolates: S. epidermidis, S. hominis, S. capitis, S. haemolyticus, and S. warneri. Regarding ABR, methicillin resistance was most frequently detected in S. haemolyticus (72%), S. cohnii (65%), and S. epidermidis (62%). S. epidermidis and S. haemolyticus showed 50–80% resistance to teicoplanin and macrolides while resistance to these agents remained lower than 10% in most other CoNS species. Conclusion: These differences are often neglected in national guideline development, prompting a focus on ‘ABR-safe’ agents such as glycopeptides. In conclusion, this multi-year, full-region approach to extensively assess the trends in both the occurrence and phenotypic resistance of CoNS species could be used for evaluating treatment policies and understanding more about these important but still too often neglected pathogens.
Cell survival and function critically relies on the fine-tuned balance of protein synthesis and degradation. In the steady state, the standard proteasome is sufficient to maintain this proteostasis. However, upon inflammation, the sharp increase in protein production requires additional mechanisms to limit protein-associated cellular stress. Under inflammatory conditions and the release of interferons, the immunoproteasome (IP) is induced to support protein processing and recycling. In antigen-presenting cells constitutively expressing IPs, inflammation-related mechanisms contribute to the formation of MHC class I/II-peptide complexes, which are required for the induction of T cell responses. The control of Toxoplasma gondii infection relies on Interferon-γ (IFNγ)-related T cell responses. Whether and how the IP affects the course of anti-parasitic T cell responses along the infection as well as inflammation of the central nervous system is still unknown. To answer this question we used triple knockout (TKO) mice lacking the 3 catalytic subunits of the immunoproteasome (β1i/LMP2, β2i/MECL-1 and β5i/LMP7). Here we show that the numbers of dendritic cells, monocytes and CD8+ T cells were reduced in Toxoplasma gondii-infected TKO mice. Furthermore, impaired IFNγ, TNF and iNOS production was accompanied by dysregulated chemokine expression and altered immune cell recruitment to the brain. T cell differentiation was altered, apoptosis rates of microglia and monocytes were elevated and STAT3 downstream signaling was diminished. Consequently, anti-parasitic immune responses were impaired in TKO mice leading to elevated T. gondii burden and prolonged neuroinflammation. In summary we provide evidence for a critical role of the IP subunits β1i/LMP2, β2i/MECL-1 and β5i/LMP7 for the control of cerebral Toxoplasma gondii infection and subsequent neuroinflammation.
Upon antigen recognition by the T cell receptor (TCR), a complex signaling network orchestrated by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs) regulates the transmission of the extracellular signal to the nucleus. The role of the PTPs Src-homology 2 (SH2) domain-containing phosphatase 1 (SHP1, Ptpn6) and Src-homology 2 (SH2) domain-containing phosphatase 2 (SHP2, Ptpn11) have been studied in various cell types including T cells. Whereas SHP1 acts as an essential negative regulator of the proximal steps in T cell signalling, the role of SHP2 in T cell activation is still a matter of debate. Here, we analyzed the role of the constitutively active SHP2-D61Y-mutant in T cell activation using knock-in mice expressing the mutant form Ptpn11D61Y
in T cells. We observed reduced numbers of CD8+ and increased numbers of CD4+ T cells in the bone marrow and spleen of young and aged SHP2-D61Y-mutant mice as well as in Influenza A Virus (IAV)-infected mice compared to controls. In addition, we found elevated frequencies of effector memory CD8+ T cells and an upregulation of the programmed cell death protein 1 (PD-1)-receptor on both CD4+ and CD8+ T cells. Functional analysis of SHP2-D61Y-mutated T cells revealed an induction of late apoptosis/necrosis, a reduced proliferation and altered signaling upon TCR stimulation. However, the ability of D61Y-mutant mice to clear viral infection was not affected. In conclusion, our data indicate an important regulatory role of SHP2 in T cell function, where the effect is determined by the kinetics of SHP2 phosphatase activity and differs in the presence of the permanently active and the temporally regulated phosphatase. Due to interaction of SHP2 with the PD-1-receptor targeting the protein-tyrosine phosphatase might be a valuable tool to enhance T cell activities in immunotherapy.
The pUS3, a serine/threonine protein kinase that is conserved in Alphaherpesvirinae may play an important in phosphorylation and regulation of the activities of viral and cellular proteins. It has also been proposed that pUS3 affects virulence. Whereas many studies of the pUS3 functions of HSV-1 and PrV, a closely related homolog of BHV-1 have supported these assumptions, the role of BHV-1pUS3 is not yet fully understood so far. The aims of this study therefore were to investigate the functions of BHV-1pUS3 for virus replication in cultured cells, effect on apoptosis and identification of protein interactions with cellular proteins and addressed the function of the aminoterminal region by generating a short isoform of BHV-1pUS3 which corresponds in size to the natural short isoforms of PrVpUS3 and HSV-1pUS3. Results of the study are briefly summarized here: -BHV-1pUS3 is, although not essential, beneficial for infectious replication of BHV-1 in-vitro. It also supports direct cell-to-cell spread of BHV-1/Aus12 and prevents the formation of electron dense aggregates with embedded capsids in nuclei of BHV-1 infected cells, a phenotype that may affect nuclear egress of BHV-1 nucleocapsids. -The protein, independent from other BHV-1 encoded functions, located mainly to the nuclei of cells. -In contrast to functions of pUS3 in PrV and HSV-1, the protein of BHV-1 has no anti-apoptotic activity. -Biologically active BHV-1pUS3 physically interacts with the cellular SET protein and overexpression of SET, independent from the expression of the protein, inhibits productive BHV-1 replication in a dose dependent manner. -The aminoterminal 101 amino acids of the protein are dispensable for all in-vitro functions tested whereas kinase activity is required.
Abstract
Platelets are small anucleate blood cells with a life span of 7 to 10 days. They are main regulators of hemostasis. Balanced platelet activity is crucial to prevent bleeding or occlusive thrombus formation. Growing evidence supports that platelets also participate in immune reactions, and interaction between platelets and leukocytes contributes to both thrombosis and inflammation. The ubiquitin‐proteasome system (UPS) plays a key role in maintaining cellular protein homeostasis by its ability to degrade non‐functional self‐, foreign, or short‐lived regulatory proteins. Platelets express standard and immunoproteasomes. Inhibition of the proteasome impairs platelet production and platelet function. Platelets also express major histocompatibility complex (MHC) class I molecules. Peptide fragments released by proteasomes can bind to MHC class I, which makes it also likely that platelets can activate epitope specific cytotoxic T lymphocytes (CTLs). In this review, we focus on current knowledge on the significance of the proteasome for the functions of platelets as critical regulators of hemostasis as well as modulators of the immune response.
T cell activation plays a central role in supporting and shaping the immune response. The induction of a functional adaptive immune response requires the control of signaling processes downstream of the T cell receptor (TCR). In this regard, protein phosphorylation and dephosphorylation have been extensively studied. In the past decades, further checkpoints of activation have been identified. These are E3 ligases catalyzing the transfer of ubiquitin or ubiquitin-like proteins to protein substrates, as well as specific peptidases to counteract this reaction, such as deubiquitinating enzymes (DUBs). These posttranslational modifications can critically influence protein interactions by targeting proteins for degradation by proteasomes or mediating the complex formation required for active TCR signaling. Thus, the basic aspects of T cell development and differentiation are controlled by defining, e.g., the threshold of activation in positive and negative selection in the thymus. Furthermore, an emerging role of ubiquitination in peripheral T cell tolerance has been described. Changes in the function and abundance of certain E3 ligases or DUBs involved in T cell homeostasis are associated with the development of autoimmune diseases. This review summarizes the current knowledge of E3 enzymes and their target proteins regulating T cell signaling processes and discusses new approaches for therapeutic intervention.
Primary and acquired therapy resistance is a major problem in patients with BRAF-mutant melanomas being treated with BRAF and MEK inhibitors (BRAFI, MEKi). Therefore, development of alternative therapy regimes is still required. In this regard, new drug combinations targeting different pathways to induce apoptosis could offer promising alternative approaches. Here, we investigated the combination of proteasome and Kv1.3 potassium channel inhibition on chemo-resistant, BRAF inhibitor-resistant as well as sensitive human melanoma cells. Our experiments demonstrated that all analyzed melanoma cell lines were sensitive to proteasome inhibitor treatment at concentrations that are not toxic to primary human fibroblasts. To further reduce proteasome inhibitor-associated side effects, and to foster apoptosis, potassium channels, which are other targets to induce pro-apoptotic effects in cancer cells, were blocked. In support, combined exposure of melanoma cells to proteasome and Kv1.3 channel inhibitor resulted in synergistic effects and significantly reduced cell viability. On the molecular level, enhanced apoptosis correlated with an increase of intracellular Kv1.3 channels and pro-apoptotic proteins such as Noxa and Bak and a reduction of anti-apoptotic proteins. Thus, use of combined therapeutic strategies triggering different apoptotic pathways may efficiently prevent the outgrowth of drug-resistant and -sensitive BRAF-mutant melanoma cells. In addition, this could be the basis for an alternative approach to treat other tumors expressing mutated BRAF such as non-small-cell lung cancer.